Chenlong Wang
Impact in
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Gut microbiota and health 2
- Co-authors
- Jing Yang (11 shared papers)Yanzhuo Liu (10 shared papers)Honglei Chen (9 shared papers)Xiaoyang Zhou (5 shared papers)Honglin Tang (6 shared papers)Miao Qiu (5 shared papers)Xuewei Chen (4 shared papers)Xuehan Chen (3 shared papers)
- Journals
- Toxicology and Applied Pharmacology (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Frontiers in Pharmacology (1 paper)Drug Metabolism and Pharmacokinetics (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Chenlong Wang
27 papers receiving 873 citations
Chenlong Wang's Hit Papers
Peers
Comparison fields: 5 of 104
- Pharmacology 109
- Biological Psychiatry 25
- Cancer Research 127
- Biochemistry 56
- Nephrology 39
Countries citing papers authored by Chenlong Wang
This map shows the geographic impact of Chenlong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenlong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenlong Wang more than expected).
Fields of papers citing papers by Chenlong Wang
This network shows the impact of papers produced by Chenlong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenlong Wang. The network helps show where Chenlong Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenlong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages Hit paper breakdown → | 2022 | 157 |
| 2 | 2019 | 89 | |
| 3 | 2019 | 77 | |
| 4 | 2012 | 74 | |
| 5 | 2019 | 64 | |
| 6 | 2015 | 58 | |
| 7 | 2018 | 55 | |
| 8 | 2018 | 54 | |
| 9 | 2018 | 38 | |
| 10 | 2017 | 34 | |
| 11 | 2022 | 28 | |
| 12 | 2020 | 27 | |
| 13 | 2024 | 25 | |
| 14 | 2018 | 24 | |
| 15 | 2024 | 12 | |
| 16 | 2018 | 11 | |
| 17 | 2023 | 10 | |
| 18 | 2023 | 9 | |
| 19 | 2022 | 7 | |
| 20 | 2021 | 6 |
About Chenlong Wang
Chenlong Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Pharmacology, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 31 papers that have together received 880 indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Gut microbiota and health (2 papers), Selenium in Biological Systems (2 papers), Mycotoxins in Agriculture and Food (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pharmacology (109 citations), Biological Psychiatry (25 citations), Cancer Research (127 citations), Biochemistry (56 citations) and Nephrology (39 citations). Chenlong Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jing Yang, Yanzhuo Liu, Honglei Chen, Xiaoyang Zhou, Honglin Tang, Miao Qiu, Xuewei Chen, Xuehan Chen, Chenfan Duan and Keqing Huang. Their work appears in journals such as Toxicology and Applied Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Journal of Experimental & Clinical Cancer Research, Frontiers in Pharmacology and Drug Metabolism and Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.